期刊文献+

膀胱内灌注纤维蛋白溶解抑制剂对卡介苗与膀胱壁结合力的影响 被引量:3

Influence upon Bacillus Calmette-Guerin attachment to bladder wall by intravesical instillation of antifibrinolytic agents
下载PDF
导出
摘要 目的 通过研究膀胱内灌注纤维蛋白溶解抑制剂对卡介苗 (BCG)与膀胱壁结合力的影响 ,探讨提高BCG抗肿瘤疗效的新方法。方法 将30只家兔在膀胱内分别行切割伤、电灼伤、冷冻伤后随机分成5组。A组膀胱内单纯灌注PBS液 ,B组灌注PBS液 +同位素标记后的BCG(3H -BCG) ,C组灌注氨基已酸 (EACA) +3H -BCG ,D组灌注氨甲苯酸 (PAMBA) +3H -BCG ,E组灌注肝素 +3H -BCG。随后切取各损伤处及未损伤处膀胱壁 ,测定其 3H -BCG的结合量。 结果 BCG在膀胱壁3种损伤处的结合量均远高于未损伤处 (均P<0.01) ;C、D组BCG的结合量均明显高于B组 (均P<0.01) ;而E组BCG结合量则明显低于B组 (P<0.01)。 结论 膀胱内灌注纤维蛋白溶解抑制剂可增强BCG与膀胱壁的结合力 ,而纤溶促进剂肝素则作用相反 ,提示前者可提高BCG的抗肿瘤疗效。 Objective To evaluate the influence upon Bacillus Calmette-Guerin (BCG) attachment to bladder wall by intravesical instillation of antifibrinolytic agents and provide a new approach of BCG instillation. Methods Thirty rabbits were equally divided into five groups and the bladder mucosa of every rabbit was injured by electrocautery,cryocautery and incision respectively. Then different drugs were instilled into bladders.Group A: pure PBS instillation;Group B:PBS and radiolabeled BCG (3H-BCG);Group C :EACA and 3H _ BCG;Group D:PAMBA and 3H-BCG;Group E:heparin and 3H-BCG. After instillation,the injured bladder wall and non-injured wall were surgically removed and the quantities of BCG adherence were determined.Results The quantity of BCG attachment to injured bladder wall was significantly higher than that of non-injured wall (P<0.01).The mean level of Group C or Group D was significantly higher than that of Group B (P<0.01) while the mean level of Group E was significantly lower than that of Group B (P<0.01). Conclusions Intravesical instillation of antifibrinolytic agent EACA or PAMBA can enhance BCG attachment to bladder wall while fibrinolytic agent heparin inhibit it. This means the former may enhance BCG antineoplastic effect.
出处 《浙江医学》 CAS 2002年第6期337-339,共3页 Zhejiang Medical Journal
基金 卫生部吴阶平泌尿外科医学研究基金资助项目(98-2-326)
关键词 膀胱内灌注 纤维蛋白溶解抑制剂 卡介苗 膀胱壁 结合力 影响 膀胱肿瘤 纤维连接蛋白 Bacillus Calmette-Guerin Bladder neoplasm Antifibrinolytic agents Fibronec_tin
  • 相关文献

参考文献1

  • 1吴阶平.泌尿外科[M].山东:山东科学技术出版社,1997.331.

共引文献12

同被引文献32

  • 1沈周俊,胡明明.膀胱癌尿液肿瘤标志物的研究和应用现状[J].临床外科杂志,2009,17(11). 被引量:8
  • 2Shen ZJ,Jin XD,Lu YL.Experimental study of fibronectin mediated drug resistance in chemotherapy for bladder cancer.Int J Uro1,2002,9(Suppl) :A33.
  • 3Lamm DL,Stogdill VD,Stogdill BJ,et al.Complication of bacillus Calmette-Guerin immunotherapy in 1,278 patients with bladder cancer.J Urol,1986,135:272-274.
  • 4Steg A,Leleu C,Debre B,et al.Systemic bacillus Calmette-Guerin infection in patients treated by intravesical BCG therapy for superficial bladder cancer.Prog Clin Biol Res,1989,310:325-334.
  • 5Ratliff TL,Palmer JO,McGarr JA,el al.Intraversical bacillus Calmette-Guerin therapy for murine bladder tumors:initiation of the response by fibronectin-mediated attachment of bacillus CametteGuerin.Cancer Res,1987,47:1762-1766.
  • 6Ratliff TL,Kavoussi LR,Catalona WJ.Role of fibronectin in intravesical BCG therapy for superficial bladder cancer.J Urol,1988,139:410-414.
  • 7Hudson MA,Yuan JJ,Catalona WJ,et al.Adverse impact of fibrin clot inhibitors on intravesical bacillus Calmette-Guerin therapy for superficial bladder tumors.J Urol,1990,144:1362-1364.
  • 8Hudson MA,Brown E J,Ritchey JK,et al.Modulation of fibronectinmediated Bacillus Calmette-Guerin attachment to murine bladder mucosa by drugs influencing the coagulation pathways.Cancer Res,1991,51:3726-3732.
  • 9Malmstrom P U, Larsson A, Johansson S. Urinary fibronectin in diagnosis and follow - up of patients with urinary bladder cancer. Br J Urol, 1993,72(3) :307 -310.
  • 10Li L Y, Yang M, Zhang H B, et al. Urinary fibronectin as a predictor of a residual tumour load after transurethral resection of bladder transitional cell carcinoma. BJU Int, 2008,102 (5) :566 - 571.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部